COVID-19 治疗相关报道

## 检测试剂

- [2020-03-17 中美上市新型冠状病毒检测试剂对比](https://mp.weixin.qq.com/s?__biz=MzA3ODgzODc5NA==&mid=2651778806&idx=1&sn=241867507717156503d81c7694487f57&chksm=8446e393b3316a856f0b8e5381f13d5b7a401e776b92af57c075d2d71c807d7be6a3721c5280&mpshare=1&scene=1&srcid=0318xetmhIcbKxoRNtN4AmfM&sharer_sharetime=1584492582044&sharer_shareid=a95d81bba82caa939c92c4c89cf532d1&exportkey=Anhhsami5IaqdwlUjPVAtbE%3D&pass_ticket=Ym0fpwqfCHTJOr2fhlHchYZ8NaqDH4zPzxIH4YkaW0zpdzFeWiSxEe6AgNZ1RNSD#rd)
![对比](https://github.com/fengqifang/CURE-COVID-19/blob/master/pic/shiji1.jpg)

## 治疗方案

- [2020-03-16 重磅|康希诺生物新冠疫苗进入临床试验招募阶段！](https://mp.weixin.qq.com/s?__biz=MzI4OTIzMzcwMw==&mid=2659320076&idx=2&sn=50075531d1b58f676ac3dab8444861a5&chksm=f744ef44c03366523e5f4dbb0d527405e35f485d7345bc067ecae68c1feee4732d700728c069&mpshare=1&scene=1&srcid=0318yCwSHpA56JZwEOlr3J3G&sharer_sharetime=1584492754342&sharer_shareid=a95d81bba82caa939c92c4c89cf532d1&exportkey=Avu9z%2FuymCwRdFmhBHGGydY%3D&pass_ticket=Ym0fpwqfCHTJOr2fhlHchYZ8NaqDH4zPzxIH4YkaW0zpdzFeWiSxEe6AgNZ1RNSD#rd)
![康希诺](https://github.com/fengqifang/CURE-COVID-19/blob/master/pic/kangxinuo.jpg)

## 疫苗相关

## 研究进展

- [2020-03-17 上海交大等多个团队联合研究发现：A型血的人更易感染新冠病毒，O型血最不易感染！](https://mp.weixin.qq.com/s?__biz=MzIwMzA1MzU5Mg==&mid=2652139183&idx=1&sn=3f40e20e154d49f18e77220f8f6d497f&chksm=8d3581d8ba4208ceb1e2fc0e4f9d6c99d0feca5ab5255b503a3cc428c19482efbb796526b92b&mpshare=1&scene=1&srcid=&sharer_sharetime=1584494317607&sharer_shareid=1276c91aef12fcece8d6cc480b1cfdf0&exportkey=AjJ6hto0PQAQmJeSn6l%2Bpdo%3D&pass_ticket=Ym0fpwqfCHTJOr2fhlHchYZ8NaqDH4zPzxIH4YkaW0zpdzFeWiSxEe6AgNZ1RNSD#rd)
![A型](https://github.com/fengqifang/CURE-COVID-19/blob/master/pic/.jpg)

## 其他

- [2020-03-13 COVID-19 Open Research Dataset Challenge (CORD-19)](https://www.kaggle.com/allen-institute-for-ai/CORD-19-research-challenge?from=timeline&isappinstalled=0)
![kaggle](https://github.com/fengqifang/CURE-COVID-19/blob/master/pic/kaggle.jpg)
